Cutaneous melanoma ranks amongst the tumor types with the highest rate of oncogenic mutations in members of the RAS–ERK pathway: 15–20% of melanomas harbor mutant NRAS, whereas oncogenic BRAF appears in 50–60% of the cases [84]. This evidence concerns the gene MAPK1 and melanoma.